Tumor infiltrating mast cells determine oncogenic HIF-2α-conferred immune evasion in clear cell renal cell carcinoma.

MLA

Xiong, Ying, et al. “Tumor Infiltrating Mast Cells Determine Oncogenic HIF-2α-Conferred Immune Evasion in Clear Cell Renal Cell Carcinoma.” Cancer Immunology, Immunotherapy, vol. 68, no. 5, May 2019, pp. 731–41. EBSCOhost, https://doi.org/10.1007/s00262-019-02314-y.

APA

Xiong, Y., Liu, L., Xia, Y., Qi, Y., Chen, Y., Chen, L., Zhang, P., Kong, Y., Qu, Y., Wang, Z., Lin, Z., Chen, X., Xiang, Z., Wang, J., Bai, Q., Zhang, W., Yang, Y., Guo, J., & Xu, J. (2019). Tumor infiltrating mast cells determine oncogenic HIF-2α-conferred immune evasion in clear cell renal cell carcinoma. Cancer Immunology, Immunotherapy, 68(5), 731–741. https://doi.org/10.1007/s00262-019-02314-y

Chicago

Xiong, Ying, Li Liu, Yu Xia, Yangyang Qi, Yifan Chen, Lingli Chen, Peipei Zhang, et al. 2019. “Tumor Infiltrating Mast Cells Determine Oncogenic HIF-2α-Conferred Immune Evasion in Clear Cell Renal Cell Carcinoma.” Cancer Immunology, Immunotherapy 68 (5): 731–41. doi:10.1007/s00262-019-02314-y.